MYH9 Facilitates Cell Invasion and Radioresistance in Head and Neck Cancer via Modulation of Cellular ROS Levels by Activating the MAPK-Nrf2-GCLC Pathway

The MYH9 (Myosin heavy chain 9), an architecture component of the actomyosin cytoskeleton, has been reported to be dysregulated in several types of cancers. However, how this molecule contributes to cancer development is still obscure. This study deciphered the molecular function of MYH9 in head and...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Guo-Rung, Chang, Joseph T., Li, Yan-Liang, Huang, Chi-Wei, Tsai, Yu-Liang, Fan, Kang-Hsing, Kang, Chung-Jan, Huang, Shiang-Fu, Chang, Po-Hung, Cheng, Ann-Joy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497050/
https://www.ncbi.nlm.nih.gov/pubmed/36139430
http://dx.doi.org/10.3390/cells11182855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497050/
https://www.ncbi.nlm.nih.gov/pubmed/36139430
http://dx.doi.org/10.3390/cells11182855

Ejemplares similares